MaxCyte Inc — Quarterly Financial Statistics (NASDAQ:MXCT) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 4.39 M7.82 M14.41 M9.85 M7.46 M 39.54 M Cash from investing activities 3.61 M-1.67 M9.53 M1.54 M5.19 M 14.59 M Cash from financing activities 228 K412 K383 K154 K14 K 963 K Free cash flow 3.98 M7.67 M13.76 M9.27 M7.16 M 37.86 M

Nachrichten

Cellares appoints Ali Soleymannezhad as chief commercial officer

MaxCyte stellt auf Stephens-Konferenz Neuausrichtung

MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript

MaxCyte verfehlt Q3-Prognosen – Aktie gibt nach

MaxCyte CFO Douglas Swirsky to step down in first half of 2026

Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates

Masoud Maher buys Maxcyte (MXCT) shares worth $102,915

Maxcyte CFO Swirsky buys $64.5k in shares

Brooke William buys Maxcyte (MXCT) shares worth $64,500

Douglas buys $111k in Maxcyte shares

Erck Stanley C, Maxcyte director, buys $137k in MXCT stock